IPO stocks in Thailand and South Korea surge on market debuts

Investors snap up shares in drugmaker SK Biopharm and glove producer Sri Trang

20200702 SK Biopharm

SK Biopharmaceuticals won approval in the U.S. for Xcopri, an epilepsy treatment last year. (Photo courtesy of  SK Biopharm)

KIM JAEWON and APORNRATH PHOONPHONGPHIPHAT, Nikkei staff writers

SEOUL/BANGKOK -- Investors in Thailand and South Korea snapped up shares in newly listed companies on Thursday, driving them sharply higher after keenly anticipated initial public offerings.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.